SG Americas Securities, LLC
Broker-DealerPosition in CATX — Perspective Therapeutics, Inc.
CIK 1313360
NEW YORK, NY
Position in CATX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$121,890
+$75,455 QoQ
Shares Held
35,745
+164.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 130 holders
Holding Since
Sep 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,826,157,704 across 45 Medical Devices names. CATX ranks #36 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
6,801,005 | $617,123,193 | |
| 2 | MDT |
Medtronic plc
|
6,500,749 | $508,553,594 | |
| 3 | BSX |
Boston Scientific Corp
|
3,785,401 | $161,560,914 | |
| 4 | NEOG |
Neogen Corp
|
9,352,065 | $84,075,064 | |
| 5 | ITGR |
Integer Holdings Corp
|
645,910 | $60,360,289 | |
| 6 | DXCM |
Dexcom Inc
|
818,912 | $55,153,723 | |
| 7 | SYK |
Stryker Corp
|
163,449 | $51,460,283 | |
| 8 | EW |
Edwards Lifesciences Corp
|
559,479 | $50,610,470 |
All Filings in CATX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,890 | 35,745 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $46,435 | 13,538 | Shares | Sole | 2025-10-23 | |
| 2025-03-31 | $44,280 | 20,789 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $83,220 | 26,088 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $246,454 | 18,461 | Shares | Sole | 2024-10-03 | |
| No filing history on record for this holder in this stock. | ||||||